Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Hong Kong
  4. Hong Kong Stock Exchange
  5. SinoMab BioScience Limited
  6. News
  7. Summary
    3681   HK0000544194

SINOMAB BIOSCIENCE LIMITED

(3681)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

SinoMab BioScience : Widens Losses in H1

08/24/2021 | 04:04am EST


© MT Newswires 2021
All news about SINOMAB BIOSCIENCE LIMITED
11/26SinoMab Was Invited to Attend the Inaugural Asia Summit on Global Health
AQ
11/23SINOMAB BIOSCIENCE : (i) CONNECTED TRANSACTION UNDER THE SUPPLEMENTAL AGREEMENT TO THE BTK..
PU
09/17EVEREST MEDICINES : Wins License to Kidney Disease Treatment; Shares Rise 4%
MT
09/16SINOMAB BIOSCIENCE : Sinovent and Everest Medicines Announce Licensing Agreement for Globa..
AQ
09/16Everest Medicines, Suzhou Sinovent Pharmaceuticals Co. Ltd. and SinoMab BioScience Limi..
CI
08/24SINOMAB BIOSCIENCE : Widens Losses in H1
MT
08/23Sinomab Bioscience Limited Reports Earnings Results for the Half Year Ended June 30, 20..
CI
06/25SINOMAB BIOSCIENCE : China Authorizes SinoMab's Lupus Drug as Treatment for Another Autoim..
MT
06/23SINOMAB BIOSCIENCE : $13 Million Bond Issuance Deal with Potential Investor Falls Through
MT
05/12SINOMAB BIOSCIENCE : Proposed election of independent non-executive director and supplemen..
PU
More news
Financials
Sales 2020 12,8  2,00  2,00 
Net income 2020 -123 M -19,2 M -19,2 M
Net cash 2020 818 M 128 M 128 M
P/E ratio 2020 -31,8x
Yield 2020 -
Capitalization 2 557 M 400 M 400 M
EV / Sales 2019 -
EV / Sales 2020 241 175 561x
Nbr of Employees 262
Free-Float 25,8%
Chart SINOMAB BIOSCIENCE LIMITED
Duration : Period :
SinoMab BioScience Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends SINOMAB BIOSCIENCE LIMITED
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Managers and Directors
Shui On Leung Chairman & Chief Executive Officer
Jianping Hua Chief Financial Officer
Dylan Carlo Tinker Independent Non-Executive Director
Ping Cho Terence Hon Independent Non-Executive Director
George William Hunter Cautherley Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
SINOMAB BIOSCIENCE LIMITED-32.61%400
CSL LIMITED10.18%101 196
WUXI BIOLOGICS (CAYMAN) INC.0.58%56 285
SAMSUNG BIOLOGICS CO.,LTD.5.33%48 100
ALEXION PHARMACEUTICALS, INC.0.00%40 336
BIOGEN INC.-0.80%35 680